Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
doi: 10.1080/14397595.2017.1280118 139 HellbergSSilvolaJMKiugelMLiljenbackHMetsalaOViljanenTet al
Glucagon-like peptide-1 (GLP-1) receptor agonists are cornerstones of both type 2 diabetes management and the private weight loss market, inhibiting the secretion of glucagon and increasing the production of insulin, and reducing food intake by slowing gastric emptying and increased satiety
The use of merbromin fluorescence quenching for the assay of silymarin in its natural source and pharmaceutical preparations
Published online March 1, 2026 DOI: 4,005 View 148 Download 1 Crossref Abstract PDFSupplementary MaterialPubReader ePub Background The growing burden of obesity has profoundly influenced the epidemiology and phenotype of diabetes
US$ 21.94
US$ 28.74
US$ 20.72
US$ 22.50
US$ 21.16
